和铂医药-B(02142.HK) 公布，拟不时于公开市场上购回价值不超过4,000万元的公司股份。
公司相信，在目前情况下进行股份购回将显示对其本身的业务展望及前景充满信心，最终使公司受益并为股东创造价值。公司目前的财务资源将使其能够在维持稳健财务状况的同时实施股份购回。
公司将随后在董事会认为适当的情况下，注销、以库存方式持有、出售或转让购回的股份。(jl/da)(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.